国邦医药：2025年第一季度净利润2.15亿元，同比增长8.17%

Group 1 - The core point of the article is that Guobang Pharmaceutical (stock code: 605507) reported its financial performance for the first quarter of 2025, showing positive growth in both revenue and net profit [1] - The company's revenue for Q1 2025 reached 1.44 billion yuan, representing a year-on-year increase of 7.57% [1] - The net profit for the same period was 215 million yuan, reflecting a year-on-year growth of 8.17% [1]